TrialsgrambêtaRCTs are beautiful
ESC Congress 2026Présenté dim. 30 août · 16:45 UTC+2Hot Line 8Tous les essais Hot Line →

NEXAF

2026

The Norwegian Exercise in Atrial Fibrillation Trial

In 295 inactive adults with non-permanent atrial fibrillation, a 12-month supervised-then-home exercise programme reduced AF burden and AF-specific quality of life at 12 months compared with usual care.

Résultat

co-primary: (1) total time in atrial fibrillation (burden, %) measured by insertable cardiac monitor over 12 months; (2) AFEQT overall score at 12 months
Différence absolue
3,2 points
NNT
32
Estimation de l’effet

relative reduction45P = 0,016

La différence absolue et le NNT sont dérivés des taux d’événements.

Également rapporté: But the co-primary quality-of-life score did not differ (AFEQT +5.6 vs +4.4; P = 0.43). Fitness rose and resting heart rate fell; total hospitalisations were 37% lower and AF-related hospitalisations 46% lower.

Publication originale
Sous-thème
Exercise
Schéma
multicentre (Trondheim, Bærum/Drammen, Tromsø), open-label, two-arm RCT; 1:1 supervised plus eHealth-based exercise vs usual care; blinded statistical analysis; 12-month follow-up with insertable cardiac monitor
Pertinence
Important: l’un des piliers parmi d’autres.
Source
Nes BM, et al. Presented at ESC Congress 2026, Hot Line 8, 30 August.

Discussion et critique

Exercise halves the time spent in atrial fibrillation, measured by an implanted monitor rather than by symptoms, the cleanest evidence yet that the arrhythmia itself responds to training. The second co-primary endpoint did not move: patients did not feel better, the same dissociation between rhythm and symptoms that the sham-controlled ablation trial in this session found. Open-label against usual care, 295 patients, and the hospitalisation figures are secondary and unadjusted for multiplicity.